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Abstract  26 
The aim of the study is to update the evidence on surgical management of 27 
endometriosis associated pain - does laparoscopic excision offers any benefits over 28 
laparoscopic ablation? This is a systematic review and meta-analysis, where we 29 
searched MEDLINE, EMBASE, ISI conference proceedings, ISRCTN, Register and 30 
Meta-register for RCTs, WHO trials search portal, Cochrane Library and the ‘British 31 
Library of electronic theses’. Three RCTs were included which enrolled 335 32 
participants with a sample size per study ranging from 24 to 178 participants. Out of 33 
these three studies, data from two could be pooled for meta-analysis. Primary 34 
outcome measure was reduction in VAS score for dysmenorrhea. Secondary outcome 35 
measures included reduction in VAS score for dyspareunia, dyschezia, chronic pelvic 36 
pain and reduction in EHP30 Core pain scores. 37 
Meta-analysis showed that the excision group had a significantly greater reduction in 38 
symptoms of dysmenorrhea (MD 0.99; 95% CI -0.02, 2.00; p = 0.05), and dyschezia 39 
(MD 1.31; 95% CI 0.33, 2.29; p = 0.009) compared with ablation. The symptoms  of 40 
dyspareunia showed non-significant benefit with excision (MD 0.96; 95% CI -0.07, 41 
1.99; p = 0.07). Data from one study showed a significant reduction in chronic pelvic 42 
pain (MD 2.57; 95% CI 1.27, 3.87; p = 0.0001) and EHP30 Core pain scores (MD 43 
13.20; 95% CI 3.70, 22.70; p = 0.006) with the excision group as compared with the 44 
ablation group. 45 
The limited available evidence shows that at twelve months post-surgery, symptoms 46 
of dysmenorrhea, dyschezia and chronic pelvic pain secondary to endometriosis 47 
showed significantly greater improvement with laparoscopic excision compared with 48 
ablation.  49 
Key words:  Laparoscopic, excision, ablation, vaporization, endometriosis, pain 50 
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Introduction 51 
The evaluation and treatment of endometriosis has evolved alongside the development 52 
of minimally invasive surgery in recent decades. This is a direct result of having a 53 
relatively simple, low morbidity means of assessing the female pelvis by diagnostic 54 
laparoscopy. Although recently we have developed the ability to accurately diagnose 55 
and map the presence of deep infiltrating endometriosis in specialist centers with 56 
readily accessible transvaginal or transrectal ultrasound (1, 2). we still lack the ability 57 
to diagnose early stage disease without diagnostic laparoscopy. Once it has been 58 
found it is recommended in ESHRE Guidelines to see and treat the lesions where 59 
possible (3) as there is evidence that their removal reduces endometriosis associated 60 
pelvic pain and improves spontaneous fertility rates (4, 5, 6).  61 
The technique used during laparoscopy for achieving this remains a contentious issue 62 
with many general gynaecologists not see-and-treating or applying only superficial 63 
electrosurgical ablation. Those with an interest in endometriosis are more likely to 64 
employ more comprehensive vaporization techniques with laser, helium gas or argon 65 
plasma therapy through to full surgical excision of lesions.  66 
A recent Cochrane review concluded that there was low quality evidence that 67 
laparoscopic excision and ablation were similarly effective in relieving pain (7). 68 
However, this review only included one trial from the medical literature. This data has 69 
been used in ESHRE Guidelines for endometriosis as grade C evidence advising that 70 
clinicians may consider both ablation and excision of peritoneal endometriosis to 71 
reduce endometriosis-associated pain (3). As there have been more studies identified 72 
on this subject, our study sought to systematically re-review and update existing 73 
evidence related to the impact of laparoscopic excision on endometriosis-associated 74 
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pelvic pain compared with laparoscopic ablation or vaporisation to further guide 75 
clinical practice.  76 
 77 
Materials and Methods 78 
Literature search methodology 79 
We searched MEDLINE (1950 to Oct 2014), EMBASE (1980 to Oct 2014). The 80 
search also included ISI conference proceedings as well as databases for registration 81 
of ongoing and archived randomised controlled trials (RCTs), namely International 82 
Standard Randomised Controlled Trial Number (ISRCTN), Register and Meta-83 
register for RCTs (http://www.controlled-trials.com), WHO trials search portal 84 
(ICTRP, apps.who.int/trialsearch/Trial). A combination of Medical Subject Headings 85 
(MeSH) and text words were used to generate two subsets of citations, one including 86 
studies of ‘endometriosis’ and the second ‘excision, ablation, diathermy, vaporisation, 87 
vaporization’. These subsets were combined using ‘AND’ to generate a subset of 88 
citations relevant to our research question. We also searched the Cochrane Library for 89 
RCTs and the ‘British Library of electronic theses’ online service (http://ethos.bl.uk) 90 
with the search term of “endometriosis”. The reference lists of all known primary and 91 
review articles were examined to identify cited articles not captured by the electronic 92 
searches. No language restrictions were placed on any of our searches. The searches 93 
were conducted independently by JP and VP. 94 
 95 
Study selection 96 
PICOS Study protocol for the review was followed. Studies were selected if the target 97 
population (P) were women undergoing laparoscopic surgery for endometriosis with 98 
any excision technique and were compared with women with any ablative or 99 
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vaporisation technique. The primary outcome measure was reduction in dysmenorrhea 100 
and secondary outcome measures were reduction in dyspareunia, dyschezia, pelvic 101 
pain, chronic pelvic pain and QoL EHP 30 pain scores. We included all randomised 102 
and non-randomised trials Only RCTs were included in this systematic review. 103 
Studies were selected in a two-stage process. Firstly, the titles and abstracts from the 104 
electronic searches were scrutinised by two reviewers independently (JP and VP) and 105 
full manuscripts of all citations that were likely to meet the predefined selection 106 
criteria were obtained. We wrote to the corresponding authors in the case where data 107 
was not clear nor reported, or a full manuscript was not available for the details. 108 
Secondly, final inclusion or exclusion decisions were made on examination of the full 109 
manuscripts. Any disagreements about inclusion were resolved by consensus or 110 
arbitration by a third reviewer (EK).  111 
 112 
Assessment of methodological quality and data extraction 113 
Each study included was assessed for sequence generation, allocation sequence 114 
concealment, blinding, incomplete outcome data, selective outcome reporting, and 115 
other potential sources of bias. The selected studies were assessed for methodological 116 
quality by using the components of study design that are related to internal validity. 117 
The assessment of methodological quality was based on the guidelines in the 118 
Cochrane Handbook for Systematic Reviews of Interventions v 5.1.0. The selected 119 
studies were assessed for methodological quality by using the components of study 120 
design that are related to internal validity (8). Two reviewers (VP and KO) completed 121 
data extraction and quality assessment (9). The information on the method of 122 
randomisation, allocation concealment, blinding, intention-to-treat analysis and 123 
follow-up rates was sought by examining the full text articles. Study characteristics 124 
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and participant features were extracted from each study.  125 
Statistical analysis 126 
From each study, outcome data were extracted by two reviewers (JP, KO). For 127 
continuous estimates, the mean difference (MD) with 95% CI was calculated using 128 
the inverse-variance method. We considered p ≤ 0.05 to be statistically significant. 129 
The results from individual studies were pooled using random-effects models because 130 
we assumed that the observed estimates of treatment effect would vary across studies 131 
because of real differences in the treatment effect in each study due to study 132 
characteristics (as well as sampling variability) (10). Heterogeneity of the exposure 133 
effects was evaluated graphically using forest plots (11) and statistically using the I
2
 134 
statistic (12). A chi-squared test for heterogeneity was also performed and the ‘p’ 135 
values are presented. Exploration of causes of heterogeneity was planned using 136 
variations in features of population, exposure and study quality. We adhered to 137 
published guidance for conducting systematic reviews throughout (i.e. The Cochrane 138 
Handbook). Statistical analyses were performed using RevMan 5.2.7 software 139 
(Cochrane Collaboration, Oxford, UK).  140 
 141 
Results 142 
Literature search 143 
The process of literature identification and selection is summarised in Figure 1. Of the 144 
502 publications identified by the search, 13 were selected during the initial 145 
screening.  After examination of the full manuscripts, 10 were excluded (Table 3) (5-146 
7, 13-19). Therefore, three studies satisfied the selection criteria and were included in 147 
this review (20, 21, 22). All these three studies were randomised trials. We did not 148 
find any non-randomised trials addressing this subject. 149 
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Study characteristics 150 
The three included RCTs enrolled 335 participants. In total, 167 women were 151 
randomised to treatment with excision and 168 women were randomised to ablation. 152 
Overall, 222 (66.3%) women completed the follow-up of the study protocol, 114 153 
(68.2%) in excision arm and 108 women in ablation arm (64.3%), with a similar rate 154 
of follow-up in both arms. The sample size per study varied across the trials and 155 
ranged from 24 to 178 participants. Out of these three studies, two were published as 156 
full manuscripts (20, 21) and one was a Doctoral thesis dissertation examined and 157 
accepted at the University of Surrey (22).   158 
The characteristics and methodological quality of the included trials are summarised 159 
in Table 1 and Table 2 respectively. Inclusion and exclusion criteria, sample size, 160 
treatment protocol and all outcomes reported are included.  Risk of bias from included 161 
studies is represented in Figures 2 and 3. Our judgments about each risk of bias item, 162 
presented as percentages across all included studies, are shown in Figure 2, and for 163 
each risk of bias item for each included study in Figure 3. All three studies had a 164 
parallel design. The method of randomisation was by computer-generated random 165 
numbers in one study (21) and by random sequence generation in blocks of 10 in two 166 
studies (20, 22).  Allocation concealment was in place in two studies (21, 22).  All 167 
studies claimed they were double-blinded, however it was not clear in the 168 
methodology of the study of Wright et al. All trials addressed incomplete outcome 169 
data.  The follow-up duration was 6 months in one study (20) and 12 months in the 170 
remaining two studies (21, 22). The follow-up rate varied between 58% and 100%. 171 
All studies performed a priori power calculation to determine the sample size needed 172 
for the outcome of pelvic pain.  173 
 174 
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Description of studies  175 
The study of Wright and colleagues included 24 women (20). It compared excisional 176 
with ablative treatment for rASRM stage 1 (mild endometriosis) (23) endometriosis in 177 
the management of chronic pelvic pain. Participants completed a questionnaire 178 
detailing symptoms related to chronic pelvic pain (pelvic pain, dysmenorrhea, 179 
dyspareunia, dyschezia, constipation, diarrhoea, cramps exercise pain, back pain, 180 
fatigue) and rated their pain on a ranked ordinal scale, pre-operatively and after 6 181 
months following surgery. Signs were assessed by the patient rating the amount of 182 
discomfort felt during palpation (uterine mobility, tenderness, adnexal pain, 183 
ultrasound scan, Pouch of Douglas). The group used 3 mm monopolar diathermy 184 
scissors with a combination of 90 watts pure cut and 50 watts coagulation for excision 185 
and a coagulation current of 50 watts with the closed end of a pair of 3 to mm 186 
monopolar laparoscopic scissors for ablation. The study reported that both treatment 187 
modalities produced good symptomatic relief and reduction in pelvic tenderness 188 
(67%). There was no significant difference between the two procedures for any of the 189 
individual questionnaire items. A high pain score before treatment was suggested to 190 
be a good predictor of appreciable improvement following surgery.  191 
 192 
The study of Healey and colleagues (21) randomised 178 women of reproductive age 193 
presenting with pelvic pain and visually proven endometriosis. Women with rASRM  194 
endometriosis stage 1-3 were included. The study recruited 89 women in each arm of 195 
excision and ablation. Out of these 95 women completed study at 12 months, 54 196 
women in excision and 49 women in ablation arm. Each subject’s endometriosis was 197 
scored and staged with use of the rASRM system and also using the superficial/deep 198 
categorization (24) at the end of the operation.  Both groups were comparable 199 
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regarding baseline patient characteristics. Women completed a questionnaire rating 200 
their various pains using visual analogue scales (VAS) pre-operatively and at 3, 6, 9, 201 
and 12 months following surgery. The study did not specify the method of excision 202 
and ablation as they allowed individual consultants to use their preferred method.  Of 203 
the excision group 87% subjects had positive histology for endometriosis. The study 204 
reported no significant difference in reduction in overall VAS pain scores at 12 205 
months following surgery between ablation and excision. They suggested that due to 206 
the non-significant trends seen in this study, a larger study may find a difference in 207 
outcomes looking at dyspareunia, rectal pain or dyschezia. Subjects were also 208 
stratified on the basis of the superficial and deep endometriosis. No significant 209 
differences were found in changes in VAS score amongst women with deep 210 
endometriosis undergoing excision or ablation. 211 
 212 
The Doctoral thesis of Barton-Smith (22) was a randomized blinded trial of CO2 laser 213 
vaporization versus harmonic scalpel excision of rASRM stage 1-3 stage 1-3 i.e. 214 
superficial and deep infiltrating endometriosis and excluded rASRM stage 4 or severe 215 
disease. The for pelvic pain recorded pre-operatively and at 3, 6 and 12 months 216 
following surgery. The hypothesis was that thorough vaporization should not be 217 
inferior to excision. The study recruited 133 women and randomised 66 to excision 218 
and 67 to ablation. 95 women completing study at 12 months, 48 in excision and 47 in 219 
ablation group. Histology was taken in 65 of 133 cases (49%), 49 from the excision 220 
group and 16 from the vaporisation group. Overall 54 of the 65 cases had histology 221 
positive for endometriosis, showing a successful correlation between visual inspection 222 
and histological analysis in 83% of cases. The proportion of women showing pain 223 
improvement was not statistically significant between the two groups though, there 224 
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was a trend towards excision being superior (85.4% excision, 72.9% vaporization). 225 
However, the extent of pain improvement in reduction of EHP30 Pain Scores was 226 
significantly better for excision compared with vaporisation at 12 months for both 227 
superficial and deep disease. VAS scores were significantly improved at 12 months in 228 
all pain domains for excision whereas vaporization showed significant improvements 229 
for dysmenorrhea and dyspareunia but not for dyschezia. Improvement in chronic 230 
pelvic pain was significantly better in excision compared with vaporisation. Analysis 231 
of deep disease alone revealed that, unlike excision, vaporization did not show a 232 
significant improvement in EHP30 Pain scores at 12 months. 233 
 234 
We could not include results from Wright et al. 2005 in this meta-analysis due to 235 
incomplete data. We pooled the data from the remaining two studies in this meta-236 
analysis where possible (21, 22). 237 
 238 
Primary outcome measure  239 
Reduction in VAS score for dysmenorrhea 240 
Pooling of the results of the two studies (21, 22) showed that the excision group had a 241 
significantly greater reduction in VAS scores of dysmenorrhea compared with 242 
ablation (MD 0.99; 95% CI -0.02, 2.00; p = 0.05; Figure 4). There was no significant 243 






p = 0.31).  244 
 245 
Secondary outcome measures 246 
Reduction in VAS score for dyspareunia 247 
Pooling of the results of these two studies (21, 22) showed that the excision group had 248 
a significantly greater reduction in VAS scores of dyspareunia compared with ablation 249 
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(MD 0.96; 95% CI -0.07, 1.99; p = 0.07; Figure 5.1). There was no significant 250 






p = 0.58).  251 
 252 
Reduction in VAS score for dyschezia 253 
Pooling of the results of these two studies (21, 22) showed that the excision group had 254 
significantly greater reduction in VAS scores of dyschezia compared with ablation 255 
(MD 1.31; 95% CI 0.33, 2.29; p = 0.009; Figure 5.2). There was no significant 256 






p 0.61). 257 
 258 
Reduction in VAS score for chronic pelvic pain 259 
One study reported on chronic pelvic pain (22), which showed a significant reduction 260 
in chronic pelvic pain with the excision group as compared with the ablation group 261 
(MD 2.57; 95% CI 1.47, 3.67; p < 0.00001, Figure 5.3). 262 
 263 
Reduction in VAS score for pelvic pain 264 
One study reported on pelvic pain (21), which showed no significant difference 265 
between the excision and ablation groups (MD -0.10; 95% CI -1.30, 1.10; p = 0.87, 266 
Figure 5.4).  267 
 268 
Reduction in EHP30 Core pain score 269 
Only one study reported on this outcome (22) This study showed that the excision 270 
group had significantly more reduction in EHP30 Core pain scores compared with 271 
ablation (MD 13.20; 95% CI 5.15, 22.25; p = 0.001; Figure 5.5).  272 
 273 
Discussion   274 
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Our systematic review identified and included three RCTs and pooled the data from 275 
two RCTs with a comparative meta-analysis of laparoscopic excision versus ablation 276 
in alleviating endometriosis associated pain symptoms. We could not include results 277 
from Wright et al. 2005 in the meta-analysis due to incomplete data (20) We pooled 278 
the data from the remaining two studies in this meta-analysis where possible (21, 22). 279 
The current Cochrane review (7) also excluded the study of Wright et al., 2005 from 280 
meta-analysis due to incomplete data and pooled data from only one RCT (21).  281 
 282 
Both the excision and ablation of endometriosis have been shown to improve pain 283 
symptoms versus controls in randomised studies at 12 months post-surgery (4,13). 284 
The main symptom of endometriosis is dysmenorrhoea which Sutton et al., reported 285 
as the worst pain symptom women complained of, and Abbott et al., reported as the 286 
most common symptom on follow up in their respective RCTs. Therefore, 287 
dysmenorrhoea was selected as the primary outcome. In this meta-analysis 288 
dysmenorrhea, dyschezia and chronic pelvic pain, all important symptoms of 289 
endometriosis, have shown significantly greater improvement from excision 290 
compared with ablation at 12 months post-surgery. The symptom of dyspareunia 291 
showed a trend towards benefit, though did not reach statistical significance. Healey 292 
et al., gave no definition for pelvic pain in his paper whereas Barton-Smith defined 293 
chronic pelvic pain as pelvic pain lasting for greater than 6 months not related to 294 
menstruation in order to differentiate it from dysmenorrhoea. Many definitions define 295 
chronic pelvic pain as including cyclical pain and, if Healey and colleagues’ definition 296 
also included cyclical menstruation pain, then the definitions are heterogeneous and 297 
are not comparable in a meta-analysis. Therefore, we did not pool these data and 298 
reported them separately. Healey et al., showed no significant improvement in any 299 
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area between the two modalities although it did show a trend towards a greater 300 
reduction in dyspareunia, rectal pain and defecation pain in the excision group 301 
compared with ablation. 302 
 303 
Strengths and limitations 304 
In general, both trials were sufficiently powered, well designed and had acceptable 305 
risk of bias summaries. Both included investigation of dysmenorrhoea, the most 306 
common symptom of endometriosis, and measured it in the same way, as well as for 307 
the secondary outcome measures of dyspareunia and dyschezia, resulting in a more 308 
than reasonable number of outcomes to compare. Both groups had more deep 309 
infiltrating disease cases in their excision groups compared with their ablation groups 310 
thus reducing the risk of bias in comparing the two trials.  311 
 312 
This meta-analysis could only pool data for Visual Analogue Scale scores for pain 313 
symptoms of dysmenorrhoea dyspareunia and dyschezia. It included quality of life 314 
data from only one study (22) that revealed significantly greater improvements in 315 
quality of life for excision compared with ablation in all EHP30 domains at 12 316 
months.  317 
 318 
The main limitation of this review remains inclusion of only three studies from the 319 
systematic review and two studies for pooling the results for meta-analysis. Some 320 
outcomes were reported in only one study. The existing meta-analysis carried out by 321 
the Cochrane group on which major national and international guidelines for 322 
management of endometriosis associated pain are based, includes only study. The 323 
reason for doing this updated review paper was therefore to provide better evidence 324 
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than that currently available as one study meta-analyses are not only pointless but can 325 
be misleading. Inclusion of two studies for meta-analysis is also not ideal but it is the 326 
best evidence we have for this important aspect of endometriosis. Furthermore, this 327 
updated review changes the results and conclusion of the previous Cochrane review 328 
and therefore will provide valuable information to update the evidence based 329 
guidelines. This will lead to change in practice and therefore more effective 330 
management of endometriosis associated pain which has been a long awaited outcome 331 
for clinicians. There is a precedent since we have all practiced for many years 332 
according to the two study meta-analysis on management of endometrioma published 333 
by the Cochrane group. We attempted to include both randomised and non-334 
randomised studies with a hope to include more studies, but we found no such studies 335 
in the literature. This highlights the difficulty in conducting such surgical trials 336 
addressing the research question and the dilemma faced by the clinicians who practise 337 
evidence based medicine, who are currently forced to adopt practice based on the 338 
current Cochrane review including one study. This updated review will provide 339 
further information on this difficult research question which is a very common clinical 340 
situation faced by many gynaecologists. 341 
 342 
The other main weakness in terms of interpreting pain in these two trials is a lack of 343 
information on co-existing adenomyosis. The presence of co-existing adenomyosis is 344 
not recorded in either paper and is likely to be a major factor affecting pain score 345 
improvements. At the time of both studies the diagnosis of adenomyosis was 346 
generally retrospective in hysterectomy specimens and not by ultrasound. 347 
Adenomyosis is now routinely diagnosed on transvaginal ultrasound and even graded 348 
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on severity of appearance (25), although this grading is only just beginning to be 349 
validated as a prognostic indicator for pain (26). 350 
 351 
For most surgeons treating endometriosis of all severities and depths, the preferred 352 
technique to be used is excision. This approach is logical as damage-prone adjacent 353 
structures like ureters, blood vessels, nerves and bowel can be dissected free by 354 
skilled surgeons to reduce the risk of complications. Furthermore, the depth of disease 355 
can be fully assessed by excising around the disease till normal tissue is seen thus 356 
achieving adequate clearance. In other words, the more complex the case, greater is 357 
the rationale for using excision as the chosen method. We may also bear in mind that 358 
the two RCTs for ablation and excision of endometriosis versus no treatment also 359 
suggested a possible advantage to excision by showing 80% versus 62.5% with 360 
ablation in women showing pain improvement at 6 months (4, 13).  361 
 362 
The case for excision would undoubtedly be more powerful if both studies were 363 
significantly in favour of excision especially as both trials were sufficiently powered, 364 
unlike in the Cochrane endometrioma review where the ambivalent result between 365 
excision and ablation came from an underpowered trial (27) That being said, our 366 
meta-analysis suggests that laparoscopic excision significantly reduces 367 
dysmenorrhoea, dyschezia and chronic pelvic pain, along with a non-significant 368 
reduction in dyspareunia, which are the most common symptom of endometriosis.   369 
 370 
Conclusion 371 
With only two trials able to be included in this meta-analysis, and one of those trials 372 
showing no statistically significant benefit for excision over ablation in any of the 373 
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outcomes, the evidence cannot be deemed as conclusive. Also, comparative data on 374 
outcomes greater than twelve months is lacking. However, at twelve months post-375 
surgery, beyond the time period of the well documented placebo effect, all the major 376 
symptoms of endometriosis of dysmenorrhea, dyschezia and chronic pelvic pain 377 
showed significantly greater improvement and a non-significant improvement in 378 
dyspareunia, with laparoscopic excision compared with ablation in this 379 
comprehensive updated systematic review.  Further well-designed and well-conducted 380 
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